NPM1 Mutation in Myeloid Malignancies - Advancing Precision Medicine
Offered By: Cancer Genomics Consortium via YouTube
Course Description
Overview
Explore the latest advancements in precision medicine for myeloid malignancies through this invited speaker presentation focusing on NPM1 mutations. Delve into the molecular testing techniques that are revolutionizing cancer diagnosis and treatment. Learn from expert Robert Hasserjian as he shares insights from the Cancer Genomics Consortium (CGC) 2023 Annual Meeting. Gain a deeper understanding of how clinical cytogeneticists, molecular geneticists, and molecular pathologists are working together to improve cancer patient outcomes through accurate genomic diagnoses. Discover the CGC's mission to establish best practices in clinical cancer genomic testing and their vision for personalized cancer care.
Syllabus
Invited Speaker Presentation - NPM1 mutation in myeloid malignancies Advancing precision medicine
Taught by
Cancer Genomics Consortium
Related Courses
Fostering Change: ACMG's New Diversity, Equity and Inclusion CommitteeAmbry Genetics via YouTube Somatic Mutations and Their Contribution to Bone Marrow Failure and Inflammation
Cancer Genomics Consortium via YouTube TP53 Alterations in Myelodysplastic Neoplasms and Acute Myeloid Leukemia
Cancer Genomics Consortium via YouTube Incorporating Genomic Information in the Treatment of MDS
Cancer Genomics Consortium via YouTube ISCN 2024 Update: Preview of New Genomic Mapping Nomenclature
Cancer Genomics Consortium via YouTube